Journal Article10.1111/J.1365-2133.1989.TB01399.X
Erythromycin resistant propionibacteria in antibiotic treated acne patients: association with therapeutic failure.
302
TL;DR: It is suggested that the use of oral erythromycin and/or topical clindamycin encourages the development of resistant propionibacteria and that the emergence of resistant strains is associated with therapeutic failure in erystromycin‐treated patients.
read more
Abstract: Erythromycin resistant (EmR) propionibacteria were isolated from the skin surface of 51% of patients treated with oral erythromycin and 42% of patients treated with topical clindamycin compared with 3% of untreated control subjects (P less than 0.001). Amongst the topical clindamycin-treated patients, there was a higher incidence of EmR propionibacterial carriage in those patients who had previously been treated with oral erythromycin (64%) than in patients with no known previous exposure to erythromycin (20%; 0.01 greater than P greater than 0.001). Patients responding to oral erythromycin treatment carried EmR propionibacteria less frequently (24%) than patients who were not responding or who had relapsed (70%; P less than 0.001). These observations suggest that the use of oral erythromycin and/or topical clindamycin encourages the development of resistant propionibacteria and that the emergence of resistant strains is associated with therapeutic failure in erythromycin-treated patients. In total 63 resistant isolates were obtained from 52 subjects. There were 42 strains of Propionibacterium acnes, 16 strains of Propionibacterium granulosum and five strains of Propionibacterium avidum. The majority of isolates were inducibly or constitutively resistant to macrolide (e.g. erythromycin), lincosamide (e.g. clindamycin) and streptogramin B type antibiotics. Therefore, the isolates are phenotypically indistinguishable from the majority of EmR bacteria in which resistance is due to methylation of 23S ribosomal RNA.
read more
Chat with Paper
AI Agents for this Paper
Find similar papers on Google Scholar, PubMed and Arxiv
Write a critical review of this paper
Analyze citations of this paper to find unaddressed research gaps
Citations
•Dissertation
Characterisation of antibiotic-resistant Propionibacterium acnes from acne vulgaris and other diseases
Cristina Oprica
- 12 May 2006
TL;DR: It is found that acne patients in Stockholm treated with antibiotics had a significantly higher risk of carrying resistant P. acnes strains, than acne patients who did not receive such a treatment, and it is demonstrated that antimicrobial resistance has emerged among P. Acnes strains isolated from different severe, lifethreatening infections in Europe.
10
Antibiotic resistance in dermatology: The scope of the problem and strategies to address it
TL;DR: In this article , a review explores dermatologic conditions in which the development of antibiotic resistance is a risk and discusses mechanisms underlying the developing of resistance, as well as disease-specific strategies for overcoming resistant strains and improving antimicrobial stewardship along with recent advances in the development approaches to counter antibiotic resistance.
10
Acne and rosacea
TL;DR: The diagnosis of acne and rosacea are reviewed in this article, and specific therapeutic strategies are discussed for these extremely common diseases.
10
The Clinical Relevance of Antibiotic Resistance: Thirteen Principles That Every Dermatologist Needs to Consider When Prescribing Antibiotic Therapy
TL;DR: Important principles gleaned from the continued efforts of the Scientific Panel on Antibiotic Use in Dermatology; other groups working diligently in this area, such as the Centers for Disease Control and Prevention and the Canadian Antimicrobial Resistance Alliance; and from the published literature are summarized.
10
References
Propionibacterium acnes resistance to antibiotics in acne patients
James J. Leyden,Kenneth J. McGinley,Stephen Cavalieri,Guy F. Webster,Otto H. Mills,Albert M. Kligman +5 more
TL;DR: The minimal inhibitory concentration of Propionibacterium acnes in seventy-five acne patients receiving long-term antibiotic therapy demonstrated the emergence of resistant strains.
236
Laboratory Induction and Clinical Occurrences of Combined Clindamycin and Erythromycin Resistance in Corynebacterium acnes
TL;DR: Corynebacterium acnes strains cross-resistant to clindamycin and erythromycin were observed following long-term selection or mutagenic treatment in the laboratory and it is suggested that this resistance may result from an alteration of the 50S ribosomal subunit.
100
Recalcitrant acne vulgaris. Clinical, biochemical and microbiological investigation of patients not responding to antibiotic treatment.
TL;DR: For most patients with recalcitrant acne a non‐microbiological explanation must be sought for the lack of therapeutic success, and the mean sebum excretion rate of the non‐responding patients was significantly higher than that of matched untreated acne patients.
45